Algeria vs United States: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Algeria
92.0%
in 2024
United States
92.0%
in 2024
Algeria rank
85th
United States rank
85th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Algeria
- United States
How they compare
Algeria currently reports 92.0% against 92.0% in United States, a difference of 0.0%.
The two have swapped places 1 time across 17 shared years of data; in 2008 it was Algeria ahead.
Algeria ranks 85th and United States ranks 85th of 192 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and United States in 1.
Head to head by decade
| Decade | Algeria | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 87.5% | 6.5% | Algeria |
| 2010s | 93.1% | 92.4% | 0.7% | Algeria |
| 2020s | 85.2% | 91.6% | 6.4% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Algeria or United States?
- Algeria, at 92.0% against 92.0% in United States as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Algeria and United States?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and United States?
- 17 years are reported by both, from 2008 to 2024.
- How do Algeria and United States rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Algeria ranks 85th and United States ranks 85th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.